Pharmedic Pharmaceutical Medicinal JSC (HNX:PMC)

Market Cap	1.05T
Revenue (ttm)	498.18B
Net Income (ttm)	80.13B
Shares Out	9.33M
EPS (ttm)	6,268.00
PE Ratio	17.87
Forward PE	n/a
Dividend	19,500.00 (16.94%)
Ex-Dividend Date	Mar 21, 2025

Volume	219
Average Volume	23,478
Open	116,400
Previous Close	116,400
Day's Range	116,400 - 116,400
52-Week Range	73,600 - 135,800
Beta	0.08
RSI	44.79
Earnings Date	Apr 18, 2025

About HNX:PMC

Pharmedic Pharmaceutical Medicinal Joint Stock Company engages in the manufacture and trade of pharmaceutical products, medicinal materials, cosmetics, medical supplies, and other products in Vietnam. The company offers non-prescription drug products for gastrointestinal and hepatobiliary; cardiovascular; respiratory; central nervous; skeletal; hormones; anti-infectives; urinary; endocrine and metabolic; vitamins and minerals; eye; ear – mouth/ throat; dermatologicals; allergy and immune; cardiovascular; diabetes; and other systems. It also pro...

• Industry: Pharmaceutical Preparations
• Founded: 1981
• Employees: 534
• Stock Exchange: Hanoi Stock Exchange
• Ticker Symbol: PMC

Financial Performance

In 2024, HNX:PMC's revenue was 498.18 billion, an increase of 2.68% compared to the previous year's 485.19 billion. Earnings were 80.13 billion, an increase of 31.36%.